WeRide Inc. (WRD) wins HKEX waiver to shift founder stakes into family trusts

Rhea-AI Filing Summary

WeRide Inc. reports that The Stock Exchange of Hong Kong Limited has granted a waiver from strict compliance with Rule 8A.18(1) of the Listing Rules. The waiver facilitates intra‑group share allotments and issuances by two British Virgin Islands entities, Xu Han Limited and Humber Partners Limited, into family trust structures for founders Dr. Tony Xu Han and Dr. Yan Li.

After these transactions, Xu Han Limited is owned 80% by Dr. Han and 20% by the trustee of his family trust, while Humber Partners is owned 80% by Dr. Li and 20% by the trustee of his family trust. Dr. Han and Dr. Li each remain protector of his respective family trust and retain sole control over the voting rights attached to the class B ordinary shares held within these structures, preserving the existing weighted voting rights framework.

Filing Explained

The waiver enables trust restructurings while the filing discloses no new WeRide shares or change in existing holders’ percentage ownership.

The July 13, 2026 Form 6-K, an interim report used by a foreign private issuer to furnish material home-market information, reports a Hong Kong listing-rule waiver granted to WeRide Inc.

The waiver facilitates planned share issuances by two companies holding WeRide shares to family-trust trustees; it does not disclose a completed change to WeRide’s share count or existing holders’ percentage ownership.

Under the disclosed structure, XHL and Humber Partners would each issue new shares so that the relevant founder retains 80% ownership and the family-trust trustee holds 20% of each entity. The filing states that Dr. Han and Dr. Li will remain trust protectors and retain sole control over the voting rights attached to the Class B shares held within their respective trust structures.

The filing records the waiver as granted, but does not state that the two entity-level allotments have been completed or provide a completion date.

Key Figures

Xu Han Limited ownership: 80% / 20% Humber Partners ownership: 80% / 20% Listing Rule reference: Rule 8A.18(1) +1 more

4 metrics

Xu Han Limited ownership 80% / 20% 80% owned by Dr. Tony Xu Han and 20% by the trustee of his family trust after share allotment

Humber Partners ownership 80% / 20% 80% owned by Dr. Yan Li and 20% by the trustee of his family trust after share allotment

Listing Rule reference Rule 8A.18(1) HKEX Listing Rule from which a waiver of strict compliance was granted

Stock code 0800 Stock code for WeRide Inc. on The Stock Exchange of Hong Kong Limited

Key Terms

weighted voting rights, Rule 8A.18(1), family trust, WVR Beneficiary, +1 more

5 terms

weighted voting rights regulatory

"a beneficiary of weighted voting rights of the Company (a “WVR Beneficiary”)"

A system where some shares carry more voting power than others so certain owners can control corporate decisions with fewer shares. Think of it like tickets to a meeting where some tickets count for five votes and others for one: it lets founders or insiders steer strategy and board picks even if they don't own most of the stock. For investors this affects corporate governance, the protection of minority shareholders, and how much influence public holders have over major decisions.

Rule 8A.18(1) regulatory

"Grant of Waiver from Strict Compliance with Rule 8A.18(1) of the Listing Rules"

family trust financial

"to the trustee of a family trust where Dr. Han is the protector"

WVR Beneficiary regulatory

"a beneficiary of weighted voting rights of the Company (a “WVR Beneficiary”)"

protector financial

"where Dr. Li is the protector and his children and descendants are the beneficiaries"

FAQ

What did WeRide Inc. (WRD) disclose in this July 2026 report?

WeRide Inc. disclosed that the Hong Kong Stock Exchange granted a waiver from Rule 8A.18(1) to allow share allotments into family trusts for founders while maintaining existing voting control arrangements.

What is the purpose of the waiver granted to WeRide Inc. (WRD)?

The waiver allows Xu Han Limited and Humber Partners Limited to allot and issue new shares to trustees of family trusts for Dr. Tony Xu Han and Dr. Yan Li, while preserving their weighted voting rights control structures.

How did ownership of Xu Han Limited change according to WeRide (WRD)?

Following the transactions, Xu Han Limited is owned 80% by Dr. Tony Xu Han and 20% by the trustee of his family trust, with Dr. Han remaining protector and retaining control over related voting rights.

How did ownership of Humber Partners Limited change for WeRide (WRD)?

Humber Partners Limited is now owned 80% by Dr. Yan Li and 20% by the trustee of his family trust, and Dr. Li continues as protector with sole control over voting rights of class B shares held in the structure.

Does the WeRide (WRD) waiver affect its weighted voting rights structure?

According to the disclosure, the founders retain sole control over voting rights attached to class B shares within their family trust structures, meaning the underlying weighted voting rights framework remains in place after the share allotments.

Who are the weighted voting rights beneficiaries at WeRide Inc. (WRD)?

The announcement identifies Dr. Tony Xu Han and Dr. Yan Li as weighted voting rights beneficiaries, serving as founder, chairman and CEO (Dr. Han) and co‑founder and CTO (Dr. Li), and as protectors of their respective family trusts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 09:12 AM Accepted by SEC EDGAR 07/13/2026 - 09:11 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number: 001-42213

WeRide Inc.

21st Floor, Tower A, Guanzhou Life Science Innovation Center

No. 51, Luoxuan Road, Guangzhou International Biotech Island

Guangzhou 510005

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x  Form 40-F ¨

EXHIBIT INDEX

Exhibit No.		Description
99.1		Announcement - Grant of Waiver from Strict Compliance with Rule 8A.18(1) of the Listing Rules, dated July 13, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WeRide Inc.
	By:	/s/ Jennifer Li
	Name:	Jennifer Li
	Title:	Chief Financial Officer

Date: July 13, 2026

Exhibit 99.1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

WeRide Inc.

文遠知行*

(A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability)

(Stock code: 0800)

GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 8A.18(1) OF THE LISTING RULES

WeRide Inc. (the “Company”) hereby advises shareholders and other investors that it has applied for, and The Stock Exchange of Hong Kong Limited has granted, a waiver (the “Waiver”) from strict compliance with Rule 8A.18(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited to facilitate (i) the allotment and issuance of new shares by Xu Han Limited (“XHL”), a British Virgin Islands company wholly owned by Dr. Tony Xu Han (“Dr. Han”), the founder, chairman of the board, executive director, chief executive officer and a beneficiary of weighted voting rights of the Company (a “WVR Beneficiary”), that holds class B ordinary shares of the Company to the trustee of a family trust where Dr. Han is the protector and his children and descendants are the beneficiaries; and (ii) the allotment and issuance of new shares by Humber Partners Limited (“Humber Partners”), a British Virgin Islands company wholly owned by Dr. Yan Li (“Dr. Li”), the co-founder, executive director, chief technology officer and a WVR Beneficiary of the Company, that holds class A ordinary shares and class B ordinary shares of the Company to the trustee of a family trust where Dr. Li is the protector and his children and descendants are the beneficiaries. Following the aforementioned share allotment and issuance, XHL is owned as to 80% by Dr. Han and as to 20% by the trustee of Dr. Han’s family trust, and Humber Partners is owned as to 80% by Dr. Li and as to 20% by the trustee of Dr. Li’s family trust. The Company applied for the Waiver, and the Waiver was granted, on the bases, among others, that each of Dr. Han and Dr. Li will remain the protector of his family trust and will retain sole control over the voting rights attached to the class B ordinary shares of the Company held within his family trust structure following the aforementioned share allotment and issuance.

By Order of the Board

WeRide Inc.

Dr. Tony Xu Han

Chairman of the Board, Executive Director and Chief Executive Officer

Hong Kong, July 13, 2026

As of the date of this announcement, the board of directors of the Company comprises Dr. Tony Xu Han and Dr. Yan Li as executive directors, Mr. Ichijo Futakawa and Mr. Jean-François Salles as non-executive directors, and Ms. Huiping Yan, Mr. David Zhang and Dr. Tony Fan-cheong Chan as independent non-executive directors.

* For identification purposes only

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 7.3 KB